U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07142239) titled 'Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome' on Aug. 19.
Brief Summary: Antiphospholipid syndrome is a thrombo-inflammatory autoimmune disorder with a complex antiphospholipid antibody-mediated pathogenesis, and high heterogeneity in clinical presentation and disease course. Clinical presentation in antiphospholipid syndrome includes venous and arterial thrombosis, pregnancy complications, and a broad range of microvascular and non-thrombotic manifestations
Study Start Date: Nov. 27, 2025
Study Type: OBSERVATIONAL
Condition:
Antiphospholipid Syndrome
Intervention:
DIAGNOSTIC_TE...